K

Kite Pharma

Develops engineered T cell cancer therapies

Associate Director - Cell Therapy Account Management

Account ManagementPosted on Nov 12
Full-time

About the Job

Requirements

  • A BA/BS and 10 years of experience, or an MA/MS and 8 years of experience, or a PhD and 2 years of experience.
  • Ability to appropriately access and handle business information in compliance with all applicable laws, regulations, and Kite policies.
  • At least 5 years of deep clinical expertise in hematology and oncology disease and understanding of the treatment landscape.
  • Demonstrated record of successful account management in large accounts, with direct or indirect line leadership experience.
  • Strong clinical understanding of cell therapy and ability to manage complex treatment logistics.
  • Direct line leadership experience.
  • Ability to manage relationships with authorized treatment centers and key account stakeholders.
  • Ability to drive appropriate utilization of CAR T therapies through compliant education and engagement.
  • Ability to develop and execute strategic account and territory plans, deliver against sales goals and key performance indicators, and grow referrals and treated-patient volume.
  • Ability to navigate academic and integrated delivery networks and identify and address barriers to care.
  • Ability to support patient access, reimbursement education, logistical coordination, and authorized treatment center readiness.
  • Ability to provide account insights, influence resource prioritization, and execute activities in compliance with company policies.

Responsibilities

  • Develop relationships with Kite’s Authorized Treatment Centers and serve as their primary point of contact with Kite.
  • Drive appropriate utilization of Kite’s CAR T therapies within assigned accounts and ensure a seamless customer experience.
  • Cultivate relationships with account stakeholders, coordinate Kite’s activities within Authorized Treatment Centers, develop strategic account plans, and communicate the value of CAR T therapy.
  • Own performance, strategy, and execution for assigned Authorized Treatment Centers and associated referral networks.
  • Drive patient identification, referrals, and therapy adoption through compliant education and engagement.
  • Differentiate Kite CAR T therapies from alternatives using approved messaging.
  • Develop and execute comprehensive account and territory plans aligned with regional and national priorities.
  • Deliver against defined sales goals, key performance indicators, and growth objectives.
  • Build trusted relationships with treating physicians, referrers, transplant teams, administrators, and key influencers.
  • Navigate complex academic and integrated delivery networks to align priorities and remove barriers to care.
  • Lead engagement across stakeholders to support class and brand growth.
  • Represent Kite at scientific congresses, speaker programs, and peer-to-peer educational forums.
  • Identify, map, and optimize patient referral pathways within hematology and oncology networks.
  • Partner with cross-functional peers to support patient access, reimbursement education, and logistical coordination.
  • Support Authorized Treatment Center readiness and comfort with CAR T processes to enable demand generation.
  • Coordinate across Medical, Market Access, Operations, and Authorized Treatment Center Onboarding teams.
  • Provide timely insights on account trends, competitive dynamics, and market opportunities.
  • Influence resource prioritization to address account-specific needs and growth opportunities.
  • Ensure all activities are executed in compliance with company policies.
  • Build sustained growth in referrals and treated patients, maintain trusted stakeholder partnerships, execute strategic account plans, and proactively identify and resolve access, operational, and market barriers.

Desired Qualifications

  • MBA.
  • Demonstrated record of successful oncology account management within an academic setting.

About the Company

Kite Pharma

Develops engineered T cell cancer therapies

Kite Pharma develops cancer immunotherapies by engineering a patient’s own T cells to attack tumors. Its core product strategy centers on cell therapy where T cells are genetically modified to recognize cancer cells, expanded outside the body, and then infused back into the patient to destroy cancer. This approach differs from traditional drugs by using the immune system itself to fight cancer and by tailoring therapies to individual patients. Kite focuses on clinical trials and commercialization of approved therapies, often through partnerships and licensing with other pharmaceutical companies to reach patients worldwide. The company’s goal is to provide potentially lifesaving, durable cancer treatments and move toward a cure for cancer.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Santa Monica, CA
Founded
2009

Recently Posted Jobs

Explore more opportunities at Kite Pharma

See more jobs